Pharmacological exploration of traditional plants for the treatment of neurodegenerative disorders
- 1 June 2020
- journal article
- review article
- Published by Wiley in Phytotherapy Research
- Vol. 34 (12) , 3089-3112
Abstract
Alzheimer's disease (AD) is clinically characterized as memory deficits, altered behavior and impaired cognitive functions. The most important risk factor for AD is aging and mounting. Evidences suggested in different studies that traditionally used plants in Asia, China, and Europe significantly affect aging and AD involved neurodegeneration pathways. Research into ethnobotanicals for impaired memory and cognition has been burgeoned in last decades. The inclusion and exclusion criteria for the plant selection were based on reputed herbs recommended for treatment of neurological disorders and their scientific validation to cure neurodegenerative disorders. A range of traditional plants imparts effects via acetylcholinesterase activity, β‐amyloid peptide formation in plaques, neurotrophic factors and through antioxidant activity. On one side preclinical investigations identified promising drug candidates for AD, on the other side, clinical evidences are still pending. Presently, according to WHO, around more than 80% world population relay on natural remedies to cure their health related issues. Plants contain rich source of primary and secondary metabolites for improving health problems. Pharmaceutical industry is facing intriguing challenges like elevated cost and unendurable risk management due to the high burden of neurodegenerative disorders. A significant shift of drug discovery is being witnessed from synthetic moieties to herbal formulation.Keywords
This publication has 194 references indexed in Scilit:
- Neuroprotective Function of DJ-1 in Parkinson’s DiseaseOxidative Medicine and Cellular Longevity, 2013
- Neurotrophins and cell deathExperimental Cell Research, 2012
- Curcumin reverses corticosterone-induced depressive-like behavior and decrease in brain BDNF levels in ratsNeuroscience Letters, 2011
- Mechanisms of neuronal dysfunction and degeneration in multiple sclerosisProgress in Neurobiology, 2011
- S-Nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegenerationMitochondrion, 2010
- Mechanism of amyloid plaque formation suggests an intracellular basis of Aβ pathogenicityProceedings of the National Academy of Sciences, 2010
- Mechanisms of chronic central neuropathic pain after spinal cord injuryBrain Research Reviews, 2009
- Mechanisms of tau-induced neurodegenerationActa Neuropathologica, 2009
- Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1receptorBritish Journal of Pharmacology, 2006
- Pathways towards and away from Alzheimer's diseaseNature, 2004